Ebola virus-induced eye sequelae: a murine model for evaluating glycoprotein-targeting therapeutics
Not Available
- Sponsoring Organization:
- USDOE
- OSTI ID:
- 2369747
- Journal Information:
- EBioMedicine, Journal Name: EBioMedicine Journal Issue: C Vol. 104; ISSN 2352-3964
- Publisher:
- ElsevierCopyright Statement
- Country of Publication:
- Netherlands
- Language:
- English
Similar Records
Characterization of the therapeutic effect of antibodies targeting the Ebola glycoprotein using a novel BSL2-compliant rVSVΔG-EBOV-GP infection model
Chimeric human parainfluenza virus bearing the Ebola virus glycoprotein as the sole surface protein is immunogenic and highly protective against Ebola virus challenge
A replication-deficient rabies virus vaccine expressing Ebola virus glycoprotein is highly attenuated for neurovirulence
Journal Article
·
2021
· Emerging Microbes & Infections
·
OSTI ID:1829743
+7 more
Chimeric human parainfluenza virus bearing the Ebola virus glycoprotein as the sole surface protein is immunogenic and highly protective against Ebola virus challenge
Journal Article
·
2009
· Virology
·
OSTI ID:21182799
+8 more
A replication-deficient rabies virus vaccine expressing Ebola virus glycoprotein is highly attenuated for neurovirulence
Journal Article
·
2012
· Virology
·
OSTI ID:22150082
+2 more